Shandong Pharmaceutical GlassLtd Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jun Zhang

Chief Executive Officer (CEO)

CN¥1.8m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	5yrs
Participación del CEO	n/a
Permanencia media de la dirección	5yrs
Promedio de permanencia en la Junta Directiva	11yrs

Actualizaciones recientes de la dirección

Recent updates

Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 26

CEO

Jun Zhang (54 yo)

5yrs

Permanencia

CN¥1,761,000

Compensación

Mr. Jun Zhang has been a General Manager of Shandong Pharmaceutical Glass Co., Ltd since May 13, 2019 and served its Deputy General Manager since May 11, 2013. Mr. Zhang was workshop Manager for Shandong P...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Jun Zhang	GM & Director	5yrs	CN¥1.76m	sin datos
Yizhao Song	CFO & Director	11yrs	CN¥609.00k	sin datos
Gang Chen	Deputy GM & Director	5yrs	CN¥1.44m	sin datos
Xingjun Wang	Deputy GM & Director	5yrs	CN¥1.45m	sin datos
Wansheng He	Deputy General Manager	no data	CN¥1.59m	sin datos
Yucai Su	Deputy General Manager	no data	CN¥1.14m	sin datos
Bin Du	Deputy General Manager	no data	sin datos	sin datos

5.0yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 600529 es experimentado (5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Jun Zhang	GM & Director	11yrs	CN¥1.76m	sin datos
Yizhao Song	CFO & Director	no data	CN¥609.00k	sin datos
Gang Chen	Deputy GM & Director	11yrs	CN¥1.44m	sin datos
Xingjun Wang	Deputy GM & Director	11yrs	CN¥1.45m	sin datos
Fali Wang	Chairman of the Supervisory Board	2yrs	CN¥1.86m	0.0015% CN¥ 282.5k
Yonggang Hu	Chairman	11yrs	CN¥2.05m	0.0089% CN¥ 1.6m
Yonggang Shen	Supervisor	11yrs	sin datos	sin datos
Weijun Gu	Independent Director	3yrs	CN¥92.00k	sin datos
Zong Bin Sun	Independent Director	3yrs	CN¥92.00k	sin datos

11.0yrs

Permanencia media

51yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de 600529 son experimentados ( 10.9 años antigüedad media).

Shandong Pharmaceutical GlassLtd Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Shandong Pharmaceutical Glass Co.Ltd, Annual General Meeting, May 16, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Shandong Pharmaceutical Glass Co.Ltd Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Shandong Pharmaceutical Glass Co.Ltd, Annual General Meeting, May 16, 2024

Shandong Pharmaceutical Glass Co.Ltd to Report Q1, 2024 Results on Apr 23, 2024

Investor sentiment improves as stock rises 16%

Shandong Pharmaceutical Glass Co.Ltd to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS exceeds analyst expectations

Shandong Pharmaceutical Glass Co.Ltd to Report First Half, 2023 Results on Aug 29, 2023

Price target decreased by 8.7% to CN¥33.37

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Triumph Science & Technology Co.,Ltd (SHSE:600552) cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd (SHSE:600529) from Shandong Luzhong Investment Co., Ltd.

Price target decreased to CN¥35.72

Investor sentiment improved over the past week

Price target decreased to CN¥35.72

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Price target decreased to CN¥38.79

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.28 (vs CN¥0.26 in 3Q 2020)

Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.8664947 billion in funding

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.21 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.23 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥40.22

Market bids up stock over the past week

New 90-day low: CN¥42.42

Third-quarter earnings released: Revenue misses expectations

Third quarter earnings released

Shandong Pharmaceutical Glass Co., Ltd to Report Q3, 2020 Results on Oct 20, 2020

New 90-day low - CN¥45.11

First half earnings released

New 90-day high - CN¥67.10

Shandong Pharmaceutical Glass Co., Ltd to Report First Half, 2020 Results on Aug 18, 2020

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad